News & Updates
Filter by Specialty:
Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
In children and adolescents with autism spectrum disorder (ASD), intranasal oxytocin did not improve social interaction or other measures of social function related to ASD, the phase II SOARS-B* trial suggests.
Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021
Overeating a marker of poor mental health, adverse outcomes among teens with diabetes
Overeating or binge eating symptoms are linked to lower quality of life, higher prevalence of depression and anxiety, and poor clinical outcomes among adolescents with type 1 diabetes, according to a study.
Overeating a marker of poor mental health, adverse outcomes among teens with diabetes
02 Dec 2021
Clinical insights on best medical therapy for peripheral artery disease
Patients with lower extremity peripheral artery disease (PAD) are at high risk for major adverse cardiovascular events (MACE), major adverse limb events (MALE), mortality, and future major lower extremity amputation (LEA). PAD patients with multivessel disease or relevant comorbidities such as diabetes and kidney failure are at an even higher risks for such events. [Lancet 2018;391:219-229]
Clinical insights on best medical therapy for peripheral artery disease
02 Dec 2021
Alternative complement pathway upregulated in severe, critical COVID-19
In patients with severe coronavirus disease 2019 (COVID-19), the leptin and alternative complement pathways are hyperactivated, which in turn might lead to greater inflammation, a new study has found.
